MarketInOut Stock Screener Log In | Sign Up

Alembic Pharmaceuticals Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:54
Alembic Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization150,351 mln
Float58.33 mln
Earnings Date11/04/2026

EPS

35.27
Exceptional

P / E

22.19
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.16
Caution advised

1-Year Forecast

961.80
Attractive

Relative Strength

68 / 100
Outperforming

Business Description

Founded over a century ago and based in Vadodara, India, Alembic Pharmaceuticals produces and sells a wide range of medicines both within India and abroad. The company covers numerous areas of healthcare, from heart disease and diabetes to eye care, skin conditions, and animal health. Its product lineup includes tablets, injections, oral liquids, and the core chemical ingredients used to make medicines.

Key Fundamentals

EPS35.27
P/E22.19
ROE12.78
RPS396
ROIC10.71
ROA8.26
Interest Cover8.46
EBITDA, mln11,648
EV / EBITDA15.56
EV / EBIT22.04
Revenue, mln77,840
EV / Revenue2.33

Quote Details

Last 782.80
Change 15.9 (2.07%)
Open 769.95
Volume 125,417
Turnover 98,176,424
Average Volume 161,829

Financial Ratios

Pre-Tax Profit Margin9
Current Ratio1.80
Price / Book2.83
Price / Tangible Book2.97
Price / Cash Flow37.32
Price / Free Cash Flow62.14
Debt / Equity0.25
Price / Sales2.08

Financial Strength

Altman Z-Score5.49
Piotroski F-Score 6 / 9
Beneish M-Score-2.16
Price to Intrinsic Value2.86
Price to Graham Number1.72
1-Year Target Price961.80
Shiller PE Ratio21.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.65% 58 / 100   
1 Month -9.37% 40 / 100   
2 Months -4.71% 60 / 100   
6 Months 3.89% 68 / 100   
1 Year -15.37% 49 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog